Halozyme Therapeutics shares owned by Linden Thomas Advisory Services
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Linden Thomas Advisory Services
from 13F filings
Historical chart of Linden Thomas Advisory Services investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Linden Thomas Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.0M | 35k | 57.24 |
| 2024-06-30 | $1.8M | 35k | 52.36 |
| 2024-03-31 | $1.7M | 43k | 40.68 |
| 2023-12-31 | $1.6M | 43k | 36.96 |
| 2023-09-30 | $1.6M | 43k | 38.20 |
| 2023-06-30 | $1.3M | 37k | 36.07 |
| 2023-03-31 | $1.4M | 37k | 38.19 |
| 2022-12-31 | $2.1M | 36k | 56.90 |
More positions owned by Linden Thomas Advisory Services
Home Depot (HD)
View all positions for Linden Thomas Advisory Services